<DOC>
	<DOCNO>NCT02390232</DOCNO>
	<brief_summary>In population patient Non Alcoholic Fatty Liver Disease ( NAFLD ) , investigator compare composition gut microbiota patient simple steatosis steatohepatitis . The purpose study determine pathogenic Escherichia Coli B2 group produce genotoxin colibactin factor develop NASH .</brief_summary>
	<brief_title>Prospective Cohort Assessing Role Genotoxin Colibactin From Escherichia Coli B2 Genesis NASH</brief_title>
	<detailed_description>Gut microbiota composition link onset obesity , metabolic disorder , Non Alcoholic Fatty Liver Disease . While simple steatosis benign prognosis , steatohepatitis ( NASH ) lead cirrhosis hepatocarcinoma increase cardiovascular cancer- related mortality . Some Escherichia coli ( E. coli ) belong B2 phylogenetic group involve many disease . Those produce genotoxin colibactin addition know induce chronic alteration intestinal permeability , one major factor lead NASH .</detailed_description>
	<mesh_term>Liver Diseases</mesh_term>
	<mesh_term>Fatty Liver</mesh_term>
	<mesh_term>Non-alcoholic Fatty Liver Disease</mesh_term>
	<criteria>NAFLD indication liver biopsy presence cause liver steatosis alcohol consumption exceed 30 g / day men 20 g / day woman history decompensated cirrhosis treatment prebiotics , probiotic antibiotic month prior inclusion chronic gastrointestinal disease history gastrointestinal surgery pregnancy breastfeed patient guardianship</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>gut microbiota</keyword>
	<keyword>Non Alcoholic Steato Hepatitis</keyword>
	<keyword>Steatohepatitis</keyword>
	<keyword>Escherichia coli</keyword>
	<keyword>colibactin</keyword>
</DOC>